Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ALNYLAM PHARMS INC

  • FDA Approval
  • Feb. 13, 2023, 19:22 UTC
  • 27
  • 0 comments

FDA approve GIVOSIRAN SODIUM

Comment Full text

BIOGEN INC

  • FDA Approval
  • Feb. 13, 2023, 19:19 UTC
  • 27
  • 0 comments

FDA approve DIROXIMEL FUMARATE

Comment Full text

BIOGEN INC

  • FDA Approval
  • Feb. 13, 2023, 19:16 UTC
  • 28
  • 0 comments

FDA approve DIMETHYL FUMARATE

Comment Full text

SANOFI AVENTIS US

  • FDA Approval
  • Feb. 13, 2023, 19:09 UTC
  • 25
  • 0 comments

FDA approve RIFAMPIN

Comment Full text

SANOFI AVENTIS US

  • FDA Approval
  • Feb. 13, 2023, 19:09 UTC
  • 26
  • 0 comments

FDA approve ISONIAZID; PYRAZINAMIDE; RIFAMPIN

Comment Full text

VALEANT LUXEMBOURG

  • FDA Approval
  • Feb. 13, 2023, 19:05 UTC
  • 29
  • 0 comments

FDA approve VERTEPORFIN

Comment Full text

MYLAN SPECIALITY LP

  • FDA Approval
  • Feb. 13, 2023, 12:52 UTC
  • 28
  • 0 comments

FDA approve TOBRAMYCIN

Comment Full text

CIPLA USA

  • FDA Approval
  • Feb. 13, 2023, 12:52 UTC
  • 28
  • 0 comments

FDA approve PLAZOMICIN SULFATE

Comment Full text

INSMED INC

  • FDA Approval
  • Feb. 13, 2023, 12:52 UTC
  • 27
  • 0 comments

FDA approve AMIKACIN SULFATE

Comment Full text

PULMOFLOW INC

  • FDA Approval
  • Feb. 13, 2023, 12:52 UTC
  • 26
  • 0 comments

FDA approve TOBRAMYCIN

Comment Full text
  • Previous
  • 884
  • 885
  • 886
  • 887
  • 888
  • Next

Search

News categories

  • Technical Exchange News(12226)
  • Event(6229)
  • SEC News(265077)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(154640)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin